Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan N Hansen

Showing results (111-120 of 116) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 116 results.
Pain|December 16, 2024
Mortality after concurrent treatment with gabapentin and opioids in older adults with spine diagnosesLaura S Gold, Patrick J Heagerty, Ryan N Hansen, et al.
Medrxiv : the Preprint Server for Health Sciences|May 15, 2024
Mortality with concurrent treatment with gabapentin and opioids among people with spine diagnoses in the U.S. Medicare population: a propensity-matched cohort studyLaura S Gold, Patrick J Heagerty, Ryan N Hansen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 17, 2014
Cost-effectiveness models for chronic obstructive pulmonary disease: cross-model comparison of hypothetical treatment scenariosMartine Hoogendoorn, Talitha L Feenstra, Yumi Asukai, et al.
Open Forum Infectious Diseases|March 9, 2018
Palivizumab Prophylaxis for Respiratory Syncytial Virus: Examining the Evidence Around ValueNatalia Olchanski, Ryan N Hansen, Elle Pope, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 8, 2016
Patient Heterogeneity in Health Economic Decision Models for Chronic Obstructive Pulmonary Disease: Are Current Models Suitable to Evaluate Personalized Medicine?Martine Hoogendoorn, Talitha L Feenstra, Yumi Asukai, et al.
The International Journal on Drug Policy|December 15, 2022
Barriers and facilitators to implementing a Pharmacist, Physician, and Patient Navigator-Collaborative Care Model (PPP-CCM) to treat hepatitis C among people who inject drugsElizabeth J Austin, Alexander J Gojic, Elenore P Bhatraju, et al.
Pageof 12

Showing results (111-120 of 116) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 116 results.
Pain|December 16, 2024
Mortality after concurrent treatment with gabapentin and opioids in older adults with spine diagnosesLaura S Gold, Patrick J Heagerty, Ryan N Hansen, et al.
Medrxiv : the Preprint Server for Health Sciences|May 15, 2024
Mortality with concurrent treatment with gabapentin and opioids among people with spine diagnoses in the U.S. Medicare population: a propensity-matched cohort studyLaura S Gold, Patrick J Heagerty, Ryan N Hansen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 17, 2014
Cost-effectiveness models for chronic obstructive pulmonary disease: cross-model comparison of hypothetical treatment scenariosMartine Hoogendoorn, Talitha L Feenstra, Yumi Asukai, et al.
Open Forum Infectious Diseases|March 9, 2018
Palivizumab Prophylaxis for Respiratory Syncytial Virus: Examining the Evidence Around ValueNatalia Olchanski, Ryan N Hansen, Elle Pope, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 8, 2016
Patient Heterogeneity in Health Economic Decision Models for Chronic Obstructive Pulmonary Disease: Are Current Models Suitable to Evaluate Personalized Medicine?Martine Hoogendoorn, Talitha L Feenstra, Yumi Asukai, et al.
The International Journal on Drug Policy|December 15, 2022
Barriers and facilitators to implementing a Pharmacist, Physician, and Patient Navigator-Collaborative Care Model (PPP-CCM) to treat hepatitis C among people who inject drugsElizabeth J Austin, Alexander J Gojic, Elenore P Bhatraju, et al.
Pageof 12